Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds
1 other identifier
interventional
56
1 country
1
Brief Summary
To evaluate wound healing with the use of Taliderm™ dressing and compare it to wet to dry dressing in the treatment of open wounds after incision and drainage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2008
CompletedFirst Posted
Study publicly available on registry
May 29, 2008
CompletedStudy Start
First participant enrolled
December 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedMarch 17, 2015
March 1, 2015
2.3 years
May 26, 2008
March 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary endpoint of this study will be rate of wound healing (judged as per cent complete wound closure) at the two (2) and three (3) week follow-up visits.
two and three weeks
Secondary Outcomes (1)
occurence of wound infection
two and three weeks
Study Arms (3)
Group II
ACTIVE COMPARATORTaliderm™ dressing applied until the next scheduled dressing change (up to eight hours), then replaced by a gauze dressing. Gauze dressing changes will continue per standard of care until the scheduled follow-up visits (first or second visit). At the scheduled follow-up visits, the subject will have a Taliderm™ dressing applied and left in place until the next scheduled dressing change (up to eight hours), then will continue standard of care wet to dry gauze dressing changes until next scheduled follow-up visit.
III
OTHERstandard wet to dry dressing with gauze
group I
ACTIVE COMPARATORTaliderm™ dressing applied until the next scheduled dressing change (up to eight hours), then replaced by a gauze dressing
Interventions
Eligibility Criteria
You may qualify if:
- Inpatients with soft tissue abscess that will result in an open surgical wounds greater than or equal to 4 cms in any dimension
- Wound will require serial dressing changes
- Greater than or equal to 18 years of age
- Ability to obtain informed consent
You may not qualify if:
- Inability to obtain informed consent
- Pregnancy
- Prisoner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
San Antonio, Texas, 78229, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
John G Myers, MD
The University of Texas Health Science Center at San Antonio
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2008
First Posted
May 29, 2008
Study Start
December 1, 2008
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
March 17, 2015
Record last verified: 2015-03